Get the app!
Back to Trades

Kaplan Matthew L.

DirectorCIK 0001895952

Largest Purchase

$64.2K

Nuvectis Pharma, Inc. (NVCT)

Nov 6

Profile

Filings
2
Buy transactions
1
Sell transactions
0
Companies
1
Active
2025–2026

Kaplan Matthew L., Director, has filed 2 reports across 1 company, totaling $64.2K in disclosed volume. The predominance of buying ($64.2K in purchases vs. $0 in sales) may reflect confidence in the underlying companies. All data sourced from SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Jun 12NVCT
Nuvectis Pharma, Inc.
Kaplan Matthew L.DirectorGrant$0
Nov 6NVCT
Nuvectis Pharma, Inc.
Kaplan Matthew L.DirectorBuy$64.2K

2 filings